About Recipharm
Recipharm is a Healthcare company based in Jordbro (Sweden) founded in 1995, and was acquired by Nichepharm in July 2024. Pharmaceutical development and manufacturing services are offered contractually. Recipharm has completed 8 acquisitions, including Arranta Bio, Consort Medical and Flamel Technologies. Its chief executive, as recorded, is Greg Behar. Its website recipharm.com draws about 22 thousand monthly visits. Recipharm offers products and services including ReciBioPharm Services, Sterile Fill and Finish, and Solids Manufacturing. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is Recipharm AB.
Company details
Recipharm operates as a pharmaceutical contract development and manufacturing company (CDMO). Its dosage forms include solid dose, sterile, semi solids, beta-lactams, hormones, dry powder inhalers, granulates, and powders. It provides pharmaceutical development services, such as formulation development, clinical supplies, analytical development, stability studies, packaging development and selection, and raw material selection; and manufacturing services, also offering EU gateway release and testing, regulatory, stability studies, and customized services. It has manufacturing facilities in Sweden, France, and the United Kingdom.
- Headquarters Jordbro, Sweden
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website recipharm.com
- Social LinkedIn YouTube
- Acquired by EQT (Dec 2020)
- Legal Name Recipharm Ab
- InvestorsEQT
& 1 more
- Investments & AcquisitionsArranta Bio
& 7 more
- Acquired by
Associated legal entities of Recipharm
Recipharm is associated with 3 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Recipharm Pharmaservices Private Limited CIN U24230MH2015PTC440983 | Active | 30 Dec 2015 | Mumbai, Maharashtra | ₹421 Cr | 1,077 | 3 | View details |
| Recipharm Holding India Private Limited CIN U74999MH2016FTC440048 | Amalgamated | 15 Mar 2016 | Mumbai, Maharashtra | ₹437 Cr | 3 | View details | |
| Recipharm Lifesciences India Private Limited CIN U51909MH2017PTC440046 | Amalgamated | 01 Feb 2017 | Mumbai, Maharashtra | ₹0.0 Cr | 3 | View details |
Products & Services of Recipharm
Recipharm offers a comprehensive portfolio of products and services, including ReciBioPharm Services, Sterile Fill and Finish, and Solids Manufacturing.
Development and GMP manufacture of ATMPs and viral vectors
Aseptic filling for vials, syringes, and lyophilisation processes
Development and manufacturing of tablets, capsules, and liquids
Apps and channels of Recipharm
its YouTube channel Recipharm CDMO has 308 subscribers and 30 videos.
Videos from Recipharm
The most watched videos on Recipharm's YouTube channel, Recipharm CDMO (308 subscribers). Click a video to play it here.
More on Recipharm CDMO.
Investors in Recipharm
Recipharm has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include EQT and Nichepharm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
EQT is recognized as a global investment organization focused on value creation. | 1994 | eqtgroup.com | Stockholm, Sweden | |
Injectable pharmaceuticals are developed and manufactured by Nichepharm. | 2019 | nichepharm.com | Gurugram, India |
Investor details for Recipharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Recipharm
The boards of the 3 registered companies of Recipharm currently have 6 directors; the longest-serving is Suresh Nagappa Ganachari, appointed in 2022. 24 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Suresh Nagappa Ganachari DIN 09805458 | Director | 28 Nov 2022 | 3 yrs 11 mo | Recipharm Holding India Private Limited, Recipharm Lifesciences India Private Limited |
| Ina Quinn DIN 09850037 | Director | 05 Jan 2023 | 3 yrs 10 mo | Recipharm Pharmaservices Private Limited |
| Emmanuel Nicolas Grand DIN 09851930 | Director | 06 Jan 2023 | 3 yrs 10 mo | Recipharm Holding India Private Limited, Recipharm Lifesciences India Private Limited |
| Daniela Schalko DIN 10927117 | Additional Director | 28 Jan 2025 | 1 yr 9 mo | Recipharm Holding India Private Limited, Recipharm Lifesciences India Private Limited |
| Sourish Mittra DIN 09829185 | Additional Director | 22 Sep 2025 | 1 yr 1 mo | Recipharm Pharmaservices Private Limited |
| Anita Ramgopal Borulkar DIN 11397289 | Additional Director | 03 Dec 2025 | 11 mo | Recipharm Pharmaservices Private Limited |
People of Recipharm
227 people are tracked at Recipharm (95 in leadership, 5 in board & advisors, 127 in team).
| Name | Role | Group |
|---|---|---|
Greg Behar | CEO | Leadership |
Ralf G. Liedke | Director IT | Leadership |
Neil Jones | Chief Commercial Officer (cco) | Leadership |
David M. | Production And Process Engineering Director / Industrial Operations | Leadership |
Teresa Karnatz | Business Development Director | Leadership |
Kieran Chouhan | General Manager, RPH Pharmaceuticals | Leadership |
Steven Harris | Associate Director Of Process Analytics, Mrna Vaccines | Leadership |
Gerardo Cappitella | Operations Director | Leadership |
Joaquim Mascaro | CFO | Leadership |
Vikas Gupta | President of ReciBioPharm | Leadership |
Luisa Amoedo | Head Of Biotech Operations | Leadership |
J.p. Fournier | Chief Financial Officer | Leadership |
Gian Luca Rossetto | HR Director | Leadership |
Edita B. | Head Of Process Analytical Technology & Data Science (continuous Manufacturing Mrna) | Leadership |
Daniel Nordbeck | Head Of IT Governance & Controlling | Leadership |
Jon Reed | Head Of Sales | Leadership |
Sylvia Godde | Director, Finance At Recibiopharm, A Business Unit Of Recipharm AB | Leadership |
Roberta Vigna | Global Quality Head Of Non Steriles | Leadership |
Aula al Muslim Celejewski | Associate Director | Leadership |
Claire Gama | Director Corporate Project Management SFF And OSD Sites | Leadership |
207 more people are available in the full profile.
Complete people profiles for Recipharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Recipharm
Figures of Recipharm Holding India Private Limited, the primary company behind Recipharm, for FY 2024. Revenue was ₹437 Cr (-25% year on year). Net loss was -₹729 Cr (-167% margin). EBITDA was -₹673 Cr (-154% margin). Revenue has grown at a compounded annual rate of -14% over three years and -7% over five years.
- ₹437 CrRevenue · FY 2024 · -25% YoY
- -₹729 CrNet loss · -167% margin
- -₹673 CrEBITDA · -154% margin
- ₹43.72 CrPaid-up capital
- -14%Revenue CAGR, 3 years
- -7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Recipharm Holding India Private Limited are on its company page.
Detailed financial statements for Recipharm
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Recipharm
Recipharm has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Arranta Bio, Consort Medical and Flamel Technologies.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of therapeutics for microbiome based diseases | arrantabio.com | Watertown, United States | 2019 | Feb 2022 | •••• | |
CDMO offering development, cGMP manufacturing and fill/finish of biologics based on viruses and bacteria | vibalogics.com | Cuxhaven, Germany | 2007 | Feb 2022 | •••• | |
Microbial and mammalian-derived products are developed and manufactured by GenIbet. | genibet.com | Oeiras, Portugal | 2006 | Feb 2022 | •••• | |
Portfolio of products for airway management and drug delivery | consortmedical.com | Hemel Hempstead, United Kingdom | 1946 | Nov 2019 | $651.44M | |
Integrated biologics development and manufacturing are provided as a CDMO. | kemwellbiopharma.com | Bengaluru, India | 1980 | Apr 2016 | $205M | |
Formulations are produced through contract manufacturing services. | mitim.it | Brescia, Italy | 1972 | Feb 2016 | $75.29M | |
CMO of small volume parenteral injectables | nitinlifesciences.com | Karnal, India | 1994 | Oct 2015 | $100.61M | |
Formulation & drug delivery company developing drugs for anaesthesia, CNS, respiratory & diabetes disorders | flamel.com | Venissieux, France | 1990 | Nov 2014 | •••• |
Complete acquisition details for Recipharm
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Recipharm
11 dated milestones of Recipharm across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Recipharm is founded.
- Acquisition Acquires Flamel Technologies.
- Acquisition Acquires Nitin Lifesciences.
- Acquisition Acquires Mitim.
- Acquisition Acquires Kemwell Biopharma.
- Acquisition Acquires Consort Medical.
- Exit Acquired by EQT.
- Acquisition Acquires GenIbet.
- Acquisition Acquires Vibalogics.
- Acquisition Acquires Arranta Bio.
- Exit Acquired by Nichepharm.
Web traffic of Recipharm
The website of Recipharm (recipharm.com) receives about 21.8K visits a month and ranks #1,103,989 among all websites worldwide, #1,368 in Biotechnology and Pharmaceuticals.
- Monthly visits21.8K
▼ 12.7% vs previous month
- Unique visitors10.3K
per month
- Global rank#1,103,989
among all websites
- Category rank#1,368
Health · Biotechnology and Pharmaceuticals
- Bounce rate42%
- Pages per visit2.0
- Average visit34 sec
- DevicesDesktop 39% · Mobile 61%
Websites whose visitors overlap most with Recipharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| outsourcedpharma.com | 100% | #1,670,166 | View details | ||
| kemwellbiopharma.com | 92% | 6.2K | #2,788,016 | View details | |
| catalent.com | 78% | 116.7K | #338,870 | View details | |
| rhoworld.com | 78% | 7.9K | #2,859,814 | View details | |
| outsourcing-pharma.com | 77% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Recipharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Recipharm
Complete news archive for Recipharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Recipharm
Recipharm was founded in 1995.
Recipharm is headquartered in Jordbro, Sweden.
Greg Behar is the CEO of Recipharm, as recorded in our data.
Recipharm operates as a pharmaceutical contract development and manufacturing company (CDMO). Its dosage forms include solid dose, sterile, semi solids, beta-lactams, hormones, dry powder inhalers, granulates, and powders. It provides pharmaceutical development services, such as formulation development, clinical supplies, analytical development, stability studies, packaging development and selection, and raw material selection; and manufacturing services, also offering EU gateway release and testing, regulatory, stability studies, and customized services. It has manufacturing facilities in Sweden, France, and the United Kingdom.
Recipharm offers ReciBioPharm Services, Sterile Fill and Finish, and Solids Manufacturing.
Recipharm has made 8 acquisitions, including Arranta Bio, Consort Medical, and Flamel Technologies.
Recipharm has 2 investors. Key investors include EQT, and Nichepharm.
Recipharm is associated with 3 legal entities: Recipharm Holding India Private Limited, Recipharm Lifesciences India Private Limited, Recipharm Pharmaservices Private Limited.
Yes. Recipharm was acquired by EQT in December 2020.
The legal entities of Recipharm currently have 6 directors, including Suresh Nagappa Ganachari, Emmanuel Nicolas Grand, Daniela Schalko and others.